Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.

AusPAR: Raltegravir

Australian Public Assessment Report

AusPAR

AusPAR: Raltegravir [PDF, 719.27 KB]

AusPAR: Raltegravir [DOCX, 764.75 KB]

Attachment: Product Information: Raltegravir [PDF, 379.32 KB]

Attachment: Product Information: Raltegravir [DOCX, 160.72 KB]

Attachment: Extract from Clinical Evaluation Report: Raltegravir [PDF, 1.29 MB]

Attachment: Extract from Clinical Evaluation Report: Raltegravir [DOCX, 2.07 MB]

Device/Product Name

Isentress

Active ingredients

Raltegravir

AusPAR Date

3 June 2013

Published

28 August 2013

Submission Number

PM-2011-03107-3-2

Submission Type

New dosage form

Decision

Approved

Product types

Prescription medicines